Previous 10 | Next 10 |
2024-01-10 09:34:22 ET Goodrx ( NASDAQ: GDRX ) shares gained as much as 9% premarket on Wednesday after the healthcare savings platform issued higher-than-expected sales for the fourth quarter of 2023. The company reported preliminary Q4 revenue in the range of $195M to $197...
Preliminary fourth quarter Revenue and Adjusted Revenue exceed previously announced guidance GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading destination for prescription savings, today provided preliminary unaudited financial res...
2024-01-08 12:18:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-01-02 13:11:40 ET More on GoodRx Holdings GoodRx Is Overvalued Without A Path To Double-Digit Growth GoodRx: Beware Of Slowing Momentum (Ratings Downgrade) GoodRx Holdings, Inc. (GDRX) Q3 2023 Earnings Call Transcript CVS hurts GoodRx with new drug prici...
2024-01-02 08:30:21 ET Losers: Corcept Therapeutics CORT -33% in patent battle with Teva . China SXT Pharmaceuticals ( SXTC ) -29% . Sentage Holdings ( SNTG ) -27% . China Green Agriculture ( CGA ) -23% . Aditxt ( ADTX ) -24% . ...
GoodRx Holdings, Inc. (Nasdaq: GDRX), a leading resource for healthcare savings and information, today announced that executives from the Company will participate in a fireside chat at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Wednesday, January 10, 2024 at 8:15 a....
2023-12-10 17:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2023-12-08 18:09:37 ET Summary GoodRx operates in the healthcare industry, providing affordable prescription medications through its platform and coupons. The company has had a volatile year, with fluctuating stock prices based on earnings reports. GoodRx is facing challenges ...
2023-12-08 17:14:32 ET Summary GoodRx, a pharmacy discount app, is facing numerous challenges including shrinking business, trouble with customers and the FTC, and the departure of its founders. The company's pivot to direct relationships with retail pharmacies may not be successf...
2023-12-05 11:39:58 ET More on CVS Health, GoodRx, etc. CVS Health: Play The Long Game CVS Health: The Core Business Model Is In Trouble CVS Health: Not One Dividend Cut In 30 Years And A Good Upside Biggest stock movers today: CVS Health, NIO, Ericsson, Noki...
News, Short Squeeze, Breakout and More Instantly...
Boehringer Ingelheim and GoodRx announce exclusive patient affordability initiative for Adalimumab-adbm injection, Boehringer's biosimilar to Humira® PR Newswire First biosimilar with an exclusive low cash price on the GoodRx platform RIDGEFIELD, Conn. and S...
GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading prescription savings platform in the U.S., today announced it will release its second quarter 2024 financial results before U.S. markets open on Thursday, August 8, 2024. GoodRx management ...
Former Genentech CEO brings over 35 years of pharmaceutical and healthcare expertise to GoodRx GoodRx Holdings, Inc. (Nasdaq: GDRX) ("we," "us," "our," “GoodRx” or the “Company”), the leading prescription savings platform in the U.S., today announced the ...